Apyx Medical (NASDAQ:APYX – Get Free Report) released its quarterly earnings data on Thursday. The company reported ($0.12) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.13) by $0.01, Zacks reports. Apyx Medical had a negative net margin of 58.59% and a negative return on equity of 137.98%. The company had revenue of $14.22 million during the quarter, compared to analyst estimates of $13.39 million. Apyx Medical updated its FY 2025 guidance to EPS.
Apyx Medical Price Performance
Apyx Medical stock opened at $1.04 on Friday. Apyx Medical has a 52-week low of $0.93 and a 52-week high of $1.99. The firm has a fifty day moving average of $1.42 and a 200-day moving average of $1.38. The firm has a market capitalization of $39.15 million, a P/E ratio of -1.25 and a beta of 1.18. The company has a quick ratio of 4.52, a current ratio of 5.46 and a debt-to-equity ratio of 3.03.
Apyx Medical Company Profile
See Also
- Five stocks we like better than Apyx Medical
- Learn Technical Analysis Skills to Master the Stock Market
- 3 Undervalued Stocks You Can Buy at a Discount Now
- CD Calculator: Certificate of Deposit Calculator
- AMD Stock: Can the PC Refresh Cycle Spark a Rally?
- What is the Australian Securities Exchange (ASX)
- Micron Stock Spikes 7%—3 Key Catalysts Behind the Move
Receive News & Ratings for Apyx Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apyx Medical and related companies with MarketBeat.com's FREE daily email newsletter.